KIMBALL WOODWARD
Specialist · WEST NYACK, NY
Individual Active NPI 1942223920
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,161 | 39,969 | $4,081,414 | $2,143,677 | $1,665,816 |
| 2023 | 1,150 | 45,137 | $5,009,044 | $2,515,820 | $1,964,377 |
| 2022 | 1,164 | 17,579 | $4,981,802 | $2,405,107 | $1,863,569 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 29,340 | $35 | $28 |
| 92134 | Imaging of retina | 2,913 | $47 | $36 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 1,506 | $151 | $110 |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | 1,100 | $109 | $87 |
| 92014 | Established patient complete exam of visual system | 949 | $148 | $109 |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 765 | $106 | $77 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 720 | $148 | $118 |
| 67028 | Injection of drug into eye | 706 | $133 | $102 |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | 391 | $18 | $14 |
| 92083 | Exam of visual field with extended testing | 259 | $75 | $55 |
| J2778 | Injection, ranibizumab, 0.1 mg | 167 | $171 | $137 |
| 92250 | Photography of the retina | 93 | $44 | $31 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Specialist | 174400000X | ✓ | 1676221 | NY |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Specialist providers in New York
- NPI 1689936387
- NPI 1326296039
- NPI 1033123542
- NPI 1437467974
- NPI 1265895585
- NPI 1699043638
- NPI 1750696365
- NPI 1801128442
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.